Decentralized antibody production systems using genetically engineered fungi (e.g., mushrooms) grown locally to produce specific therapeutic antibodies. Residents can cultivate edible antibodies using small-scale, sustainable farms in households and communities. It promotes community resilience and reduces reliance on large-scale pharmaceutical manufacturing.